Loading
Latest filing published 09 Mar 2023 for F-star Therapeutics, Inc., €197k.
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
All filings by Louis Kayitalire on record concern F-star Therapeutics, Inc., in the capacity of senior executive. We count 8 filings; the first trade dates from 20 November 2020 and the latest from 8 March 2023.
Every open-market trade on record is a sale: 4 sales worth €8,275. Besides market trades, the filings include 2 share grants.
Most recently, on 9 March 2023, the filings show a transaction worth €169k in F-star Therapeutics, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. For comparison, the SEC allows two business days to file a Form 4. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
5 of 5 declarations